Dergiler / The Anatolian Journal of Cardiology / 2019 / Cilt: 21 - Sayı: 1

Circular RNA expression profies of persistent atrial firillation in patients with rheumatic heart disease

Sayfa
2–10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Furthermore, we constructed correlated expression networks betweencircRNAs and miRNAs. circRNA19591, circRNA19596, and circRNA16175 interacted with 36, 28, and 18 miRNAs, respectively; miR-29b-1-5p andmiR-29b-2-5p were related to 12 down-regulated circRNAs, respectively.Conclusion: Our findings provide a novel perspective on circRNAs involved in AF due to rheumatic heart disease and establish the foundationfor future research of the potential roles of circRNAs in AF. (Anatol J Cardiol 2019; 21: 2-10)

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To investigate the expression profile of circular RNAs (circRNAs) and proposed circRNA–microRNA (miRNA) regulatory network inatrial fibrillation (AF).Methods: Atrial tissues from patients with persistent AF with rheumatic heart disease and non-AF myocardium with normal hearts were collected for circRNA differential expression analyses by high-throughput sequencing.
📊
Temel Bulgular & Veri:Quantitative reverse transcription polymerase chain reaction (PCR) was performed to validate the results.Results: A total of 108 circRNAs were found to be differentially expressed in AF.
💡
Sonuç & Katkı:Furthermore, we constructed correlated expression networks betweencircRNAs and miRNAs. circRNA19591, circRNA19596, and circRNA16175 interacted with 36, 28, and 18 miRNAs, respectively; miR-29b-1-5p andmiR-29b-2-5p were related to 12 down-regulated circRNAs, respectively.Conclusion: Our findings provide a novel perspective on circRNAs involved in AF due to rheumatic heart disease and establish the foundationfor future research of the potential roles of circRNAs in AF. (Anatol J Cardiol 2019; 21: 2-10)
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: To investigate the expression profile of circular RNAs (circRNAs) and proposed circRNA–microRNA (miRNA) regulatory network inatrial fibrillation (AF).Methods: Atrial tissues from patients with persistent AF with rheumatic heart disease and non-AF myocardium with normal hearts were collected for circRNA differential expression analyses by high-throughput sequencing. The Gene Ontology (GO) and Kyoto Encyclopedia of Genesand Genomes (KEGG) pathway enrichment analyses were performed to predict the potential functions of the differentially expressed genes andAF-related pathways. Co-expression networks of circRNA–miRNA were constructed based on the correlation analyses between the differentially expressed RNAs. Quantitative reverse transcription polymerase chain reaction (PCR) was performed to validate the results.Results: A total of 108 circRNAs were found to be differentially expressed in AF. Among them, 51 were up-regulated, and 57 were down-regulated. Dysregulated circRNAs were validated by quantitative real-time PCR. The GO and KEGG pathway enrichment analyses were executed todetermine the principal functions of the significantly deregulated genes. Furthermore, we constructed correlated expression networks betweencircRNAs and miRNAs. circRNA19591, circRNA19596, and circRNA16175 interacted with 36, 28, and 18 miRNAs, respectively; miR-29b-1-5p andmiR-29b-2-5p were related to 12 down-regulated circRNAs, respectively.Conclusion: Our findings provide a novel perspective on circRNAs involved in AF due to rheumatic heart disease and establish the foundationfor future research of the potential roles of circRNAs in AF. (Anatol J Cardiol 2019; 21: 2-10)

🔖

Bu Makaleye Atıf Yap

HU, M., WEİ, X., Lİ, M., TAO, L., WEİ, L., ZHANG, M., CHENG, H., XIAO, Y. Y. (2019). Circular RNA expression profies of persistent atrial firillation in patients with rheumatic heart disease. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 1, 2–10. https://ajindex.com/articles/365262

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res 2017; 120: 1501-17
  2. Kuck KH, Fürnkranz A, Chun KR, Metzner A, Ouyang F, Schlüter M, et al.; FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J 2016; 37: 2858-65
  3. Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, et al. Radiofrequency ablation vs antiarrhythmic drugs as firstline treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA 2014; 311: 692-700
  4. Nattel S, Dobrev D. Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol 2016; 13: 575-90
  5. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011; 91: 265-325
  6. Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med 2015; 25: 475-84
  7. Reumann M, Bohnert J, Osswald B, Hagl S, Doessel O. Multiple wavelets, rotors, and snakes in atrial fibrillation--a computer simulation study. J Electrocardiol 2007; 40: 328-34
  8. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-66
  9. Tsai CT, Lai LP, Hwang JJ, Lin JL, Chiang FT. Molecular genetics of atrial fibrillation. J Am Coll Cardiol 2008; 52: 241-50
  10. Rossi A, Enriquez-Sarano M, Burnett JC Jr, Lerman A, Abel MD, Seward JB. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 2000; 35: 1256-62
  11. Hancox JC, James AF, Marrion NV, Zhang H, Thomas D. Novel ion channel targets in atrial fibrillation. Expert Opin Ther Targets 2016; 20: 947-58
  12. Lee S, Choi E, Cha MJ, Hwang KC. Looking into a conceptual framework of ROS-miRNA-atrial fibrillation. Int J Mol Sci 2014; 15: 21754-76
  13. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006;15 Spec No 1: R17-29
  14. Daniel C, Lagergren J, Öhman M. RNA editing of non-coding RNA and its role in gene regulation. Biochimie 2015; 117: 22-7
  15. Dykes IM, Emanueli C. Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. Genomics Proteomics Bioinformati